Evidence map›Paper›PMID 31209394›Full record

ArticleNature genetics2019

Quantitative evidence for early metastatic seeding in colorectal cancer.

Zheng Hu, Jie Ding, Zhicheng Ma, Ruping Sun, Jose A Seoane, J Scott Shaffer, Carlos J Suarez, Anna S Berghoff, Chiara Cremolini, Alfredo Falcone and 5 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Nature genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06594692 (Node-sparing Modified Short-Course Radiation Combined With CAPOX and Sintilimab for MSS Locally Advanced Colon Cancer), which is not on this map. Cited by 274 papers.

0numbers the graph read from it
0cells of the map it votes in
274citing papers in PubMed
26.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06594692 phase2not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Node-sparing Modified Short-Course Radiation Combined With CAPOX and Sintilimab for MSS Locally Advanced Colon Cancer : A Randomized, Prospective, Multicenter, Open-label Clinical Trial

TypeinterventionalSponsorSir Run Run Shaw HospitalRan2024 to 2026Enrolled140ConditionsMicrosatellite Stable (MSS) Colon Cancer, Locally Advanced Colon CancerArmsNode-Sparing Short-Course Radiotherapy Combined with CAPOX and Sintilimab, CAPOX Chemotherapy
3 · Its place in the literature

Who cites it

274 citing papers in PubMed, 513 citations in OpenAlex.

  1. Trial
  2. Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

214 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Zheng HuDepartment of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Jie DingDepartment of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Zhicheng MaDepartment of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Ruping SunDepartment of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-3702-9483
Jose A SeoaneDepartment of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-3856-9177
J Scott ShafferStanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Carlos J SuarezDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Anna S BerghoffComprehensive Cancer Center CNS Tumor Unit, Medical University of Vienna, Vienna, Austria.
Chiara CremoliniDepartment of Oncology, University Hospital of Pisa, Pisa, Italy.
Alfredo FalconeDepartment of Oncology, University Hospital of Pisa, Pisa, Italy.
Fotios LoupakisUnit of Medical Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, IRCCS, Padua, Italy.
Peter BirnerComprehensive Cancer Center CNS Tumor Unit, Medical University of Vienna, Vienna, Austria.
Matthias PreusserComprehensive Cancer Center CNS Tumor Unit, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-3541-2315
Heinz-Josef LenzDepartment of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Christina CurtisDepartment of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA. cncurtis@stanford.edu.ORCID http://orcid.org/0000-0003-0166-3802
Stanford University · USComprehensive Cancer Center Vienna · ATAzienda Ospedaliera Universitaria Pisana · ITIstituto Oncologico Veneto · ITStanford Medicine · USUniversity of Southern California · USVeracyte (United States) · US

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
Forecasting tumor evolution: can the past reveal the future?DP1CA238296 · NCI · STANFORD UNIVERSITY · PI CURTIS, CHRISTINA N · 2018 to 2022
$5.5M
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance MechanismsU01CA217851 · NCI · STANFORD UNIVERSITY · PI CURTIS, CHRISTINA N, JI, HANLEE P · 2017 to 2021
$4.7M
NCI NIH HHS DP1 CA238296NCI NIH HHS P30 CA014089NCI NIH HHS P30 CA124435NCI NIH HHS U01 CA217851
6 · The paper itself

Abstract

Both the timing and molecular determinants of metastasis are unknown, hindering treatment and prevention efforts. Here we characterize the evolutionary dynamics of this lethal process by analyzing exome-sequencing data from 118 biopsies from 23 patients with colorectal cancer with metastases to the liver or brain. The data show that the genomic divergence between the primary tumor and metastasis is low and that canonical driver genes were acquired early. Analysis within a spatial tumor growth model and statistical inference framework indicates that early disseminated cells commonly (81%, 17 out of 21 evaluable patients) seed metastases while the carcinoma is clinically undetectable (typically, less than 0.01 cm

Indexed as

Gene Expression Regulation, NeoplasticBiomarkers, TumorBrain NeoplasmsCase-Control StudiesColorectal NeoplasmsDNA Copy Number VariationsGene Expression ProfilingGenomicsHumansLiver NeoplasmsRetrospective StudiesBiomarkers, Tumor

Identifiers

PMID31209394
PMCPMC6982526
OpenAlexW2950945543

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.